Fingerprint
Dive into the research topics of 'A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism
Joseph R. Moskal*, Jeffrey Burgdorf, Roger A. Kroes, Stefan M. Brudzynski, Jaak Panksepp
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
67
Scopus
citations